Register entry
SHORLA PHARMA LTD
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 7
- Countries
- 0
Exclusivity
Patents and exclusivities
7| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11771701 | JYLAMVOmethotrexate | product | Oct 2034 |
| 12605385 | JYLAMVOmethotrexate | product | Oct 2035 |
| 11129833 | JYLAMVOmethotrexate | product | Oct 2035 |
| 11975013 | TEPYLUTEthiotepa | product | Aug 2041 |
| 12622921 | TEPYLUTEthiotepa | use | Aug 2041 |
Enquiry
Common questions
- Is SHORLA PHARMA LTD FDA approved?
- SHORLA PHARMA LTD holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.